Phase III Clinical Trial Evaluating the Efficacy and Safety of 5-aminolevulinic Acid (5-ALA)
Condition(s):5-aminolevulinic Acid; Fluorescence-guided ResectionLast Updated:December 8, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):5-aminolevulinic Acid; Fluorescence-guided ResectionLast Updated:December 8, 2023Not yet recruiting
Condition(s):Kidney Transplant ImmunosuppressionLast Updated:November 2, 2023Recruiting
Condition(s):Herpes ZosterLast Updated:April 10, 2023Not yet recruiting
Condition(s):Breakthrough PainLast Updated:September 8, 2022Not yet recruiting
Condition(s):Kidney Transplant Recipients; BK VirusLast Updated:March 24, 2022Not yet recruiting
Condition(s):NSAIDs-associated Intestinal Mucosal InjuryLast Updated:April 4, 2022Unknown status
Condition(s):Patients With Iron Deficiency Anemia in GynecologyLast Updated:February 15, 2022Unknown status
Condition(s):Postmenopausal Vulvovaginal AtrophyLast Updated:November 1, 2022Active, not recruiting
Condition(s):DiabetesLast Updated:July 16, 2021Unknown status
Condition(s):Extensive-stage Small-cell Lung CancerLast Updated:February 2, 2024Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.